Ibuprofen API Market Size & Share, by Application (Headache, Arthritis); End-User (CROs & CMOs, Pharmaceutical & Biopharmaceutical Companies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

Growth Drivers

• Growth in Number of Women Menstruating - Approximately 1.8 billion people worldwide experience menstruation each month, which corresponds to 800 million women and girls experiencing menstruation daily, or 26 percent of the world's population. However, menstruation also brings in excessive pain. Dysmenorrhea, or period pain and cramps, are common. Most women and girls endure pain during their menstrual cycle, however to various degrees of severity. Some women experience such severe pain which further limits their physical activity. The womb frequently creates an excessive amount of the chemical messenger prostaglandin in women experiencing severe menstrual discomfort. This causes excruciating lower abdominal pains which may also hurt the thighs or back. Hence, ibuprofen is frequently employed to treat period discomfort. This pharmaceutical is classified as non-steroidal anti-inflammatory drugs (NSAIDs). Through this process of prostaglandin inhibition, it can alleviate the discomfort associated with menstruation.
• Rise in Need for Growth in Drug Development - With the growing prevalence of various diseases, the demand for drugs is moving upward which is further demanding a rise in drug development. However, most of the time the cost of producing medications hinders the development. Hence, a substantial amount of the research and manufacturing activities of many pharmaceutical corporations are outsourced to drug manufacturing companies. For companies without the internal resources or funding to produce ibuprofen APIs internally, outsourcing the manufacturing process may prove beneficial. Additionally, it reduces the duration of production. Manufacturers and inventors may meet development timeframes by outsourcing ibuprofen APIs and benefiting from great supply chain efficiency.
• Surge in Prevalence of Musculoskeletal Disorders in Pediatric - As a result of insufficient sports participation and incorrect posture, MSD issues frequently start in childhood. Musculoskeletal pain throughout childhood or adolescence raises the likelihood of developing it later in life, probably as a result of the formation of unhelpful attitudes, actions, and beliefs about the earlier pain occurrences. As a result, the demand for ibuprofen is predicted to rise. 

Challenges

• Strict Regulation on Ibuprofen API - Before approving a medicine, regulatory bodies must thoroughly review the relevant data. They examine things such as drug interactions, pharmacological information, safety, and efficacy. Drug applicants risk receiving a comprehensive response letter (CRL) or a complete denial from regulatory bodies if their product fails to satisfy any of these requirements. After obtaining a CRL, a drug applicant must offer more information regarding the medication, which could need further clinical trials and raise the medication's R&D costs. Drug candidates frequently withdraw their applications and end their drug studies. These kinds of things may hinder ibuprofen APIs from being adopted. As a result, the demand for ibuprofen API market is projected to hinder over the coming years.
• High Price of Ibuprofen API - There may be a downturn in the market share of ibuprofen formulations (medicines) in the upcoming years due to the shortage of Ibuprofen active pharmaceutical ingredient (API) around the world, which has caused inflation.
• Not Prevalence to Every Kind of Illness